Navigation Links
AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives
Date:1/26/2009

TUSTIN, Calif., Jan. 26 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a leading vertically integrated bio-pharmaceutical company with operations in the U.S. and China, announced today its fiscal year 2009 preliminary financial guidance and first quarter business objectives.

Fiscal Year 2008 Guidance

AMDL reaffirms its fiscal year 2008 financial guidance of gross revenues in the previously announced range of US$32 million to $36 million, which represents more than a 100% increase over the US$15 million in gross revenues in fiscal year 2007. For fiscal year 2008, AMDL estimates net income after taxes but before foreign currency translation gains of between US$900,000 and $1.3 million. Comprehensive gains after foreign currency translations are estimated to be between US$2.4 and $2.6 million, a downward adjustment that is due to the recently announced equity incentive plan and one-time adjustment for severance payments accrued for AMDL's prior CEO.

Fiscal Year 2009 Preliminary Guidance

AMDL has successfully achieved over 100% gross revenue growth for the past consecutive four years and expects to achieve a comparable gross revenue growth rate for fiscal year 2009 with estimated gross revenues of US$64 million to $72 million and net income between US$8 million and $12 million after taxes and before foreign currency translation gains or losses for its China-based operations only.

This represents an approximate 100% increase in gross revenues over the Company's fiscal year 2008 performance and does not include sales revenue projections for the AMDL ELISA DR-70(R) (FDP) cancer test or export sales for the Company's Human Placental Extract (HPE) anti-aging product line, both of which AMDL anticipates it will begin selling in the second quarter of 2009. AMDL believes anticipated revenues from these two products could potentially re
'/>"/>

SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
2. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
3. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
4. AMDL, Inc. Closes Private Placement of Convertible Notes
5. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
6. AMDL, Inc. Announces Strategic Realignment
7. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
8. AMDL, Inc.s President & CEO Mr. Gary Dreher Retires
9. AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
10. AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
11. AMDL, Inc. New President & CEO Douglas MacLellan to Present at Rodman & Renshaw Annual Global Investment Conference November 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... (PRWEB) May 16, 2013 A ... portable models, from Cole-Parmer is designed to meet ... line includes: , The new Cole-Parmer® MS-3400 ... workhorses in the lab. They ensure a powerful ... plasma specimen separation. Their standard four-place swinging buckets ...
(Date:5/16/2013)... 2013  The registration deadline has been extended until ... 2013 National Conference, the premier conference for bioscience financial ... the Hilton San Diego Bayfront. "We ... and want to make sure as many people as ... Brandi Roberts , Chief Financial Officer of Mast ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ...   Competitor Analysis: ... Biosuperiors http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The ...
(Date:5/16/2013)... Dr. Stephen Y. Chou, Founder of Nanonex Corporation, ... Applications” at IEEE Nano 2013 in Beijing, China, on ... Chou, is becoming one of the most critical nanofabrication ... nm resolution, large area, and low cost unmatchable by ... manufacturing in a broad range of industries, from ICs, ...
Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... Calif., June 26 Duska Therapeutics,Inc. (OTC Bulletin ... its company information is available via Standard & ... program, a full,description of Duska Therapeutics is published ... a recognized securities manual for secondary,trading in approximately ...
... Most Pioneering Healthcare Innovations in 21st ... ... Agendia BV, a world,leader in gene expression analysis-based diagnostics, is pleased ... MammaPrint(R) test from the Dutch Innovation Platform.,MammaPrint, a 70-gene signature diagnostic ...
... ValGenesis, Inc., a leading,provider of Enterprise Validation ... ValGenesis 2.0, the latest version of its,breakthrough ... automation product., Life science companies implementing ... entire validation life cycle and move securely ...
Cached Biology Technology:Duska Therapeutics Obtains Standard & Poor's Listing 2Agendia's MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform 2Agendia's MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform 3ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0 2ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0 3
(Date:5/16/2013)... a fast food restaurant had a higher body mass ... fast food, according to researchers at The University of ... particularly strong among those with a lower income. ... American Journal of Public Health indicates higher BMI ... and among lower-income African-Americans, the density, or number, of ...
(Date:5/16/2013)... PA, May 16, 2013 The relationship between ... (IQ) has not been clear. Schizophrenia is commonly ... disability. There are clues that reduced IQ may ... For example, reduced cognitive ability may precede the ... be present in healthy relatives of people diagnosed ...
(Date:5/16/2013)... bone marrow in the liver, the spleen or ... that a specific type of immune cell facilitates such ... is essential for the function of the immune system. ... liver and the spleen. Later the process is delegated ... as the sole source of blood cells for the ...
Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Genetic risk for schizophrenia is connected to reduced IQ 2Herpes infections: Natural killer cells activate hematopoiesis 2
... Journal of Lipid Research suggests an unusual form ... of diabetes, especially in children and young adults, in the ... kids get half their genes from mom and half from ... of inheritance like metabolic programming, which occurs when an insult ...
... livening up boring bran flakes; it can also ... Institute of Standards and Technology (NIST) have developed ... the sugars pharmaceutical companies use to stabilize protein-drugs ... their findings* at the 236th American Chemical Society ...
... studying stroke and Sudden Infant Death Syndrome will present ... Specialized Neuroscience Research Programs in New York Aug. 19-22, ... Basic Neuroscience Program at the UAF Institute of Arctic ... SNRP whose goal is to expand and stimulate basic ...
Cached Biology News:Candy-coating keeps proteins sweet 2Stroke and SIDS in Alaska topics of neuroscience conference 2